title: Efficacy and safety of thalidomide in the treatment of multiple myeloma.
authors.affiliation: Institute of Hematology and Transfusion Medicine, 14 Indira Gandhi St., 02-776 Warsaw, Poland.
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Warzocha
authors.forename: Maria
authors.initials: M
authors.lastname: Kraj
authors.forename: Ryszard
authors.initials: R
authors.lastname: Pogłód
authors.forename: Tomasz
authors.initials: T
authors.lastname: Szpila
authors.forename: Ewa
authors.initials: E
authors.lastname: Mendek-Czajkowska
authors.forename: Monika
authors.initials: M
authors.lastname: Chełstowska
authors.forename: Renata Hagedorna
authors.initials: RH
authors.lastname: Tronina
mesh_terms: D000328:Adult; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D012008:Recurrence; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide